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Abstract Article Info 
Intoduction: Cytochrome P450 2E1 (CYP2E1) is the enzyme as a part of CYP 450 enzyme families. It acts in 
phase I metabolism which result in the formation of electrophilic molecule and elevation of reactive oxygen 
species (ROS).   
Discussion: ROS is formed by the metabolism reaction of CYP2E1. This molecules is responsible in 
development of cancer by damaging the protein and DNA, leading to mutation and increase cell proliferation. 
Nitrosamine as the most carcinogen for nasopharyngeal carcinoma (NPC) is the substrate of this enzyme. This 
chemical is contained in the salted fish, tobacco smoke, beer, and preserved food such as meat product. 
Conclusion: Nitrosamine needs CYP2E1 to activate the pro-carcinogen in order to act its carcinogenic effect. 
Polymorphism of CYP2E1 is associated with higher transcriptional activity and enzyme activity. Therefore, the 
ability of CYP2E1 to activate pro-carcinogen of nitrosamine will be increased, leading to higher chance to 
develop cancer, including NPC. 
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Cytochrome P450 2E1 (CYP2E1) is member of CYP 450 
superfamily [1, 2]. CYP2E1 is expressed and acts its role in the liver  
[3]. This enzyme had function in metabolism of drugs and chemical 
substances [4, 5]. It has responsibility in pro-carcinogens activation of 
several cancer. Nitrosamines as the chemical carcinogens have been 
found in meat, tobacco smoke and food color additives and the pro -
carcinogens of this compound is activated by CYP2E1[6, 7]. CYP2E1 
activates this xenobiotics into toxic substances and the induction is the 
first step in chemical induced carcinogens [8].  
Nasopharyngeal carcinoma (NPC) is malignancies which rare in 
the world but common in Southern China and Southeast Asia  [9]. In 
Indonesia, this cancer is frequent and the overall incidence of NPC 
estimated at 6.2/100 000 or about 12 000 new cases per year  [10]. 
NPC is developed by the association of genetic abnormalities, Epstein 
Barr Virus (EBV) infection and the environmental factor such as 
consumption of salted fish, smoked fish/meat, smoking, and alcohol 
consumption [11, 12]. Alteration of genes responsible in immune 
regulation, carcinogens metabolism, DNA damage and repair also 
tumorigenesis were known associated with NPC [13]. Polymorphism 
of CYP2E1 as enzyme acts in metabolism of carcinogens is a risk 
factor for NPC. 
Several studies have found the polymorphism of CYP2E1 in 
cancers including gastrointestinal cancer, breast cancer, lung cancer and 
also head and neck cancer[14-16]. Polymorphism of the gene which is 
the homozygote variant type (T allele/c2c2/(-/-))  is associated with 
higher transcription and activity of CYP2E1 than the wild type 
(c1/c1/(+/+)) [17, 18]. Nitrosamine is contained in salted preserved 
food and tobacco as the environmental risk factor of NPC [19]. The 
polymorphism of CYP2E1 might be increase the activity of the enzyme 
to activate pro-carcinogens leading to the development of NPC. 
2. MAIN TEXT 
2.1 Carcinogen in NPC 
NPC can be induced by the environmental factors including dietary 
factors, tobacco and alcohol intake [20]. Those factors is associated in the 
development of NPC due to carcinogens which is contained in them. 
Carcinogens is the chemical substances causing cancer [21]. Generally, 
carcinogens is divided by genotoxic type and non-genotoxic type as well as 
its mechanism in initiating cancer, genotoxic and non-genotoxic mechanism 
[22, 23]. Most of the causes is genotoxic carcinogens with its effect in 
triggering DNA mutation or chromosomal aberration. This substances 
interfere cell progression, proliferation, differentiation, DNA replication and 
repair and also in apoptotic pathways. Carcinogens regulate cell cycle by 
acceleration or arrest cell cycle progression including induce cell cycle 
arrest in G1 phase, increase G1 phase, activating cell cycle checkpoints due 
to DNA damage formation and also enhance cells to enter into S phase 
which one of the causes is nitrosamine [22, 24].  Non-genotoxic carcinogens 
accounts for 10-20% carcinogens and works in carcinogenesis by altering 
epigenetics, endocrine system, apoptotic signaling, cell proliferation and/or 
gap-junctional intercellular communication [23].  
Above, we stated that carcinogens can be genotoxic and non-genotoxic with 
genotoxic is more dominant induce cancer. These genotoxic substance include 
microcystins-LR (MCLR), polycyclic aromatic hydrocarbons, aromatic amines, 
N-nitrosamines, aflatoxins, and benzene, 2-Amino-3-methylimidazo [4,5-
f]quinoline (IQ), aflatoxin B1 (AFB1), benzo[a]pyrene (BaP) and cisplatin 
(CisPl) and many others [22, 25].  N-nitrosamines is the carcinogens which can 
be found in air, water, foods, cosmetics, tobacco and packing materials [26]. This 
is one of the carcinogen responsible in enhancing NPC.  
There was several study which showed the association of N-
nitrosamine with cancer. It was showed that nitrosamine induced bladder 
cancer [27]. Other study presented that nitrosamine such as nicotine-derived 
nitrosamine ketone (NNK) can induce formation of radical oxygen species 
and leading to lung cancer [28]. N-Dinitrosopiperazine also had been known 
can induce nasopharyngeal carcinoma and also its metastasis [29]. 







In food such as meat, salted fish, beer and water, N-nitrosamines are the 
result of the reaction between organic amine or secondary amine and their 
derivatives with the nitrosating compounds such as nitrogen oxide or nitrite. 
Nitrite is mostly used as preservation of meat products. In beer, water and 
also food, N-nitrosodimethylamine (NDMA) is the common type of N-
nitrosamine which has been found. The method of cooking also affect the 
content of nitrosamines in it. Food which was fried and baked contains 
higher N-nitrosamine than the raw one. The temperature of 990C-1850C 
was effective to increase N-nitrosamine formation [26, 30]. 
In the tobacco, nitrite is formed by microbe on or in the plant before, 
during and after curing. The reaction between nitrite as the predominant 
nitrogen oxide with nicotine produces tobacco specific nitrosamines 
(TSNAs) [31]. Types of TSNAs with the most carcinogenic effect are NNK 
and N-nitrosonornicotine (NNN) [32]. However, besides TSNAs, there is 
another carcinogen in person who smokes tobacco, tar. Tar is genotoxic 
substance in tobacco smoke. It is composed of carcinogenic compounds 
such as benzopyrene, dibenzanthracene, and other polyaromatic 
hydrocarbons which cause free radical formation [33]. 
2.2 Metabolism of genotoxic carcinogen and CYP2E1  
Metabolism is the process of change of chemicals from one part of 
chemicals to another by enzyme. The aim of metabolism is for 
detoxification by excreting endogenous and/or exogenous molecules from 
the body. It converts lipophilic chemicals to hydrophilic one so that it can 
eliminated from the body [34, 35]. Metabolism mostly consists two-step 
process, phase I and phase II. Phase I is the process of oxidoreductions and 
hydrolysis, showing nucleophilic groups [36]. Phase I metabolism can 
produce the products which is reactive intermediates and more toxic by 
bioactivation [35]. This phase is through the cytochrome P450 (CYP450) 
enzymes activity. However, phase II is the process which is conjugation of 
nucleophilic groups with endogenous molecule including glucuronic acid or 
glutathione so it can be more hydrophilic and less toxin and then excreted 
from the body. It works by the activity of Glutathione S- Transferase (GST), 
NAD(P)H: Quinone oxidoreductase (NOO), Cytosolic sulfotransferases 
(SULT), Epoxide hydrolase (EPHX), UDP-Glucuronosyl transferase 
(UGT), Methyltransferase (MT), N-Acetyltransferase (NAT) [34, 37]. 
Genotoxic carcinogen is needed to underwent metabolism in order to 
activate the carcinogen effect [22]. Most this carcinogens are pro-
carcinogens which need activation to form the electrophilic substance and 
perform the genotoxic effect [38]. As we have said before, the activation of 
chemicals to nucleophilic group is done by CYP450 enzymes group in the 
phase I metabolism. This enzyme is involved in the activation of potential 
pro-carcinogens [39]. The enzymes activity requires oxygen activation, 
leading to reactive oxygen species (ROS) formation including superoxide 
anion (O2), hydrogen peroxide (H2O2), and hydroxyl radical (OH). ROS 
are harmful to the cells due to their action to denature proteins, inactivate 
enzymes and cause RNA and DNA damage [40].  
CYP2E1 is part of CYP enzymes which is involved in metabolic 
activation of more than 85 xenobiotics to become hepatotoxic and 
carcinogenic. This enzyme is distributed in liver, kidneys, nasal mucosa, brain 
and lungs [41]. The gene is located on chromosome 10q26.3. It has role in the 
bioactivation of ethanol, acetone, benzene, N-nitrosamine and vinyl chloride 
[42]. CYP2E1 has great ability in generating ROS due to uncoupling of 
oxygen consumption with NADPH oxidation. It is supported by its high level 
of expression in mitochondria. The oxidative stress which signed by the 
elevation of ROS is responsible in the development of cancer [43]. It causes 
the damage of protein, DNA, and/or lipid, result in chromosome instability, 
genetic mutation, and/or enhancing of cell growth [44].  
Nitrosamine can induced the cancer by activation of CYP2E1 enzyme. 
Gao at al. in their study found the effect of CYP2E1 activity for the pro-
carcinogen activation of diethylnitrosamine (DEN) as the most common 
nitrosamine. It showed by the increase of hepatofibrosis along with higher 
CYP2E1 activity. This was supported by decrease of fibrosis with CYP2E1 
inhibitors used. Pro-carcinogen of nitrosamine as the substrate for CYP2E1 
is enhanced after the induction of CYP2E1 and it is reduced by inhibitors of 
CYP2E1[6]. Nitrosamine need metabolic activation by CYP2E1 activity to 
show its carcinogen effect which is increase the intracellular ROS levels 
[45]. As we have said above, ROS is responsible for carcinogenesis due to 
its act in damaging DNA and protein.  
2.3 Polymorphism of CYP2E1 in NPC 
Polymorphism of CYP2E1 has known to be associated with several 
cancer. The polymorphism of this enzyme is related with higher activity of 
CYP2E1. Genetic variance of this gene is more than 160 missense and the 
T allele which is the substitution of a thymine instead of cytosine in wild 
type allele of CYP2E1 (rs2031920) has the ability in increasing 
transcriptional activity[46]. The minor T allele is one of polymorphism of 
CYP2E1 which has been known to has higher transcriptional activity and 
enzyme activity than the major allele or C allele [18].  
However, CYP2E1*5B PstI (rs3813867) is polymorphism of 
CYP2E1 which is the result of substitution of cytosine instead of guanine 
in the 1259 position of wild type allele of CYP2E1. The heterozygous 
c1/c2 and homozygous mutant c2/c2 genotyped has decrease of enzyme 
activity. CYP2E1*6 DraI (rs6413432) is polymorphism with the 
substitution of adenine instead of thymine in 7678 position of wild type 
allele of CYP2E1. CC homozygous mutant of this enzyme is associated 
with higher enzyme activity [16]. 
It was showed that polymorphism of CYP2E1 which is CYP2E1*D 
were significantly associated with oral caners. It was related with the risk 
factor of oral cancer, tobacco and alcohol consumption which contains 
carcinogen including nitrosamine and polycyclic aromatic hydrocarbons 
[47]. Karakoc et al., found that the heterozygous mutant of CYP2E1-RsaI 
(rs2031920) polymorphism had higher risk for head and cancer 
susceptibility [16].  Anuradha et al., also found the association of CYP2E1 
polymorphism with the increase risk of head and neck cancer. The risk is 
increases if CYP2E1 act in tobacco carcinogens metabolism [48]. 
For NPC, it was showed that subjects with homozygous variant 
genotype had higher risk for NPC, 2.2 fold than subjects with wild type and 
heterozygous genotype. They also found that the risk was higher in the 
subjects who smoking, 3.3 fold than nonsmokers [49]. This study showed 
the effect of CYP2E1 which increased by smoking. It supports the evidence 
that CYP2E1 has role in NPC development by activating pro-carcinogens, 
such as nitrosamine which is contained in tobacco smoke. Another study 
showed the increase risk for NPC in individual with CYP2E1 
polymorphism. There were five of ten single-nucleotide polymorphisms 
(SNPs) including rs9418990, rs915908, rs8192780, rs1536826, rs3827688 
were associated with increased risk of NPC [50]. 
3. CONCLUSION 
Development of NPC is multifactorial process by genetic, 
environmental, and EBV infection. Polymorphism of CYP2E1 is one of 
genetic involvement for NPC due to alteration of the enzyme and 
transcriptional activity. CYP2E1 act in phase I metabolism which result in 
formation electrophilic molecule and ROS generation. The most carcinogen 
of NPC is nitrosamines which is contained in tobacco smoke, salted fish and 
preserved food and this chemicals need activation of their pro-carcinogens 
by CYP2E1 to show their carcinogens effect. Polymorphism of CYP2E1 is 
associated with the increase of pro-carcinogens activation leading to 
development of NPC. 
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